Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Diagnosis
95 results:

  • 1. Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.
    Strickland MR; Lander EM; Gibson MK; Ilson DH; Ajani JA; Klempner SJ
    J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38503041
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Assessment of HER1 (rs11543848) and her2 (rs1136201) polymorphism and their association with colorectal cancer susceptibility in Khyber Pakhtunkhwa, Pakistan.
    Ullah A; Khan BM; Khan NU; Muntaha ST; Khan S; Khan AU; Almutairi MH; Ali I
    Mol Biol Rep; 2023 Dec; 51(1):1. PubMed ID: 38040921
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeting erbb2/her2 genetic alterations: an expanding therapeutic opportunity in gastrointestinal cancers.
    Zheng-Lin B; Graham RP; Bekaii-Saab TS
    Chin Clin Oncol; 2023 Oct; 12(5):55. PubMed ID: 37964543
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review.
    Lawler T; Parlato L; Warren Andersen S
    Cancer Causes Control; 2024 Feb; 35(2):223-239. PubMed ID: 37688643
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in her2-positive invasive breast cancer patients: a nationwide analysis.
    Ploumen RAW; Claassens EL; Kooreman LFS; Keymeulen KBMI; van Kats MACE; Gommers S; Siesling S; van Nijnatten TJA; Smidt ML
    Breast Cancer Res Treat; 2023 Sep; 201(2):227-235. PubMed ID: 37395816
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The role of area-level socioeconomic disadvantage in racial disparities in cancer incidence in metropolitan Detroit.
    Purrington KS; Hastert TA; Madhav KC; Nair M; Snider N; Ruterbusch JJ; Schwartz AG; Stoffel EM; Peters ES; Rozek LS
    Cancer Med; 2023 Jul; 12(13):14623-14635. PubMed ID: 37184135
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Targeting her2 in colorectal cancer].
    Spitzer E; Cervera P; André T; Cohen R
    Bull Cancer; 2023 Apr; 110(4):402-411. PubMed ID: 36870811
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Urachal carcinoma: The journey so far and the road ahead.
    Kumar R; Harilal S; Abdelgawad MA; Ghoneim MM; Kumar A; Mathew B
    Pathol Res Pract; 2023 Mar; 243():154379. PubMed ID: 36821941
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event.
    Zwimpfer TA; Schwab FD; Steffens D; Kaul F; Schmidt N; Geiger J; Geissler F; Heinzelmann-Schwarz V; Weber WP; Kurzeder C
    World J Surg Oncol; 2023 Feb; 21(1):40. PubMed ID: 36755294
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Circ-erbb2 knockdown sensitized colorectal cancer cells to 5-FU via miR-181a-5p/PTEN/Akt pathway.
    Zhang Y; Wang X; Wang S; Liu J; Li R; Li X; Zhang R
    J Biochem Mol Toxicol; 2023 Apr; 37(4):e23297. PubMed ID: 36639866
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies.
    Powell CA; Modi S; Iwata H; Takahashi S; Smit EF; Siena S; Chang DY; Macpherson E; Qin A; Singh J; Taitt C; Shire N; Camidge DR
    ESMO Open; 2022 Aug; 7(4):100554. PubMed ID: 35963179
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.
    Zuo Y; Zhong J; Bai H; Xu B; Wang Z; Li W; Chen Y; Jin S; Wang S; Wang X; Wan R; Xu J; Fei K; Han J; Yang Z; Bao H; Shao Y; Ying J; Song Q; Duan J; Wang J
    EBioMedicine; 2022 Aug; 82():104165. PubMed ID: 35901658
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Microsatellite Instability-High Endometrial cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles.
    Manning-Geist BL; Liu YL; Devereaux KA; Paula ADC; Zhou QC; Ma W; Selenica P; Ceyhan-Birsoy O; Moukarzel LA; Hoang T; Gordhandas S; Rubinstein MM; Friedman CF; Aghajanian C; Abu-Rustum NR; Stadler ZK; Reis-Filho JS; Iasonos A; Zamarin D; Ellenson LH; Lakhman Y; Mandelker DL; Weigelt B
    Clin Cancer Res; 2022 Oct; 28(19):4302-4311. PubMed ID: 35849120
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
    Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
    Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Natural History of Human Epidermal Growth Factor Receptor 2-Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic colorectal cancer in US Clinical Practice.
    Schröder C; Gower-Page C; Reyes-Rivera I; Patel A; Price R; Sen S; Davies J; Castellanos E; Snider J; Bai X; Fisher V; Mhatre SK
    JCO Clin Cancer Inform; 2022 Mar; 6():e2100133. PubMed ID: 35297649
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. diagnosis and Treatment of erbb2-Positive Metastatic colorectal cancer: A Review.
    Strickler JH; Yoshino T; Graham RP; Siena S; Bekaii-Saab T
    JAMA Oncol; 2022 May; 8(5):760-769. PubMed ID: 35238866
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Ongoing and evolving clinical trials enhancing future colorectal cancer treatment strategies.
    Ros J; Saoudi N; Salvà F; Baraibar I; Alonso G; Tabernero J; Elez E
    Expert Opin Investig Drugs; 2022 Mar; 31(3):235-247. PubMed ID: 35133234
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Interstitial Lung Disease Induced by Anti-erbb2 Antibody-Drug Conjugates: A Review.
    Tarantino P; Modi S; Tolaney SM; Cortés J; Hamilton EP; Kim SB; Toi M; Andrè F; Curigliano G
    JAMA Oncol; 2021 Dec; 7(12):1873-1881. PubMed ID: 34647966
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. her2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients.
    Abdul Razzaq EA; Venkatachalam T; Bajbouj K; Rahmani M; Mahdami A; Rawat S; Mansuri N; Alhashemi H; Hamoudi RA; Bendardaf R
    Libyan J Med; 2021 Dec; 16(1):1955462. PubMed ID: 34319852
    [No Abstract]    [Full Text] [Related]  

  • 20. Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways.
    Sihag S; Nussenzweig SC; Walch HS; Hsu M; Tan KS; Sanchez-Vega F; Chatila WK; De La Torre SA; Patel A; Janjigian YY; Maron S; Ku GY; Tang LH; Hechtman J; Shah PM; Wu AJ; Jones DR; Molena D; Solit DB; Schultz N; Berger MF
    Clin Cancer Res; 2021 Jun; 27(12):3491-3498. PubMed ID: 33795256
    [TBL] [Abstract] [Full Text] [Related]  


    of 5.